Peak6 Investments LLC Novartis Ag Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $1.33 Million - $1.56 Million	17,868 New	17,868 $1.36 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $319,558 - $361,483	-3,989 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $212,161 - $234,602	2,662 Added 200.6%	3,989 $349,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $56,182 - $65,361	-687 Reduced 34.11%	1,327 $109,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $2.25 Million - $2.49 Million	-27,384 Reduced 93.15%	2,014 $175,000
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $1.47 Million - $2.07 Million	-20,866 Reduced 41.51%	29,398 $2.42 Million
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $3.7 Million - $4.12 Million	50,264 New	50,264 $4.31 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.